GRPR and cancer: While 68Ga-RM2 has emerged as the lead GRPr imaging agent, others have been developed and demonstrated similarly excellent cancer imaging characteristics, including 64Cu-Sarcophagine–Bombesin (64Cu-SAR-BBN).